Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatic fibrogenesis.

Jinsheng Guo1, Scott L Friedman

  • 1Division of Liver Diseases, Mount Sinai Hospital, Mount Sinai School of Medicine, New York, New York 10029, USA.

Seminars in Liver Disease
|November 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexual dimorphism in the association of circulating TAM receptors-ligands with MASLD-related fibrosis.

JHEP reports : innovation in hepatology·2026
Same author

Erratum to 'Hot and cold fibrosis: The role of serum biomarkers to assess immune mechanisms and ECM-cell interactions in human fibrosis' [J Hepatol 83 (2025) 239-257].

Journal of hepatology·2026
Same author

Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis.

Cell·2026
Same author

Cannabinoid receptor 2 activating antibodies: A promising therapeutic strategy for macrophage-driven fibro-inflammatory diseases.

Molecular pharmacology·2026
Same author

Scar-associated endothelial-stellate cellular crosstalk drives fibrosis resolution in MASH.

Cell reports·2026
Same author

Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis.

Science translational medicine·2026
Same journal

Endothelial Cell Therapy for the Acute and Chronic Liver Disease.

Seminars in liver disease·2026
Same journal

Neutrophils in Liver Diseases: Functions and Challenging Therapies.

Seminars in liver disease·2026
Same journal

Expert Practical Recommendations for Hepatocellular Carcinoma.

Seminars in liver disease·2026
Same journal

Optimizing Liver Cancer Care Through BCLC Principles.

Seminars in liver disease·2026
Same journal

Patient-Derived Models of Liver Cancer to Inform Clinical Treatment Paradigms: Recent Updates.

Seminars in liver disease·2026
Same journal

Practical Guide to Best Practices in Alcohol-Associated Liver Disease.

Seminars in liver disease·2026
See all related articles

Hepatic fibrogenesis, the liver

Area of Science:

  • Hepatology
  • Fibrosis Research
  • Extracellular Matrix Biology

Background:

  • Hepatic fibrogenesis is a liver wound-healing response to injury.
  • It leads to cirrhosis, causing significant global morbidity and mortality.
  • Key contributors include activated hepatic stellate cells and fibrocytes.

Purpose of the Study:

  • To review the mechanisms of hepatic fibrogenesis.
  • To highlight the imbalance between extracellular matrix synthesis and degradation.
  • To discuss mediators and pathways involved in liver fibrosis.

Main Methods:

  • Literature review of hepatic fibrogenesis.
  • Analysis of extracellular matrix accumulation in liver injury.
  • Identification of signaling pathways and genetic factors.

Related Experiment Videos

Main Results:

  • Increased extracellular matrix synthesis by hepatic stellate cells and fibrocytes.
  • Impaired extracellular matrix degradation due to matrix metalloproteinase inhibitors.
  • Identification of numerous mediators amplifying the fibrogenic response.

Conclusions:

  • Understanding hepatic fibrogenesis is crucial for treating chronic liver diseases.
  • Advances in signaling pathways and genetic determinants promise new diagnostics and therapies.
  • Transformative treatments for chronic liver disease patients are anticipated.